DK0804182T3 - Anvendelse af gabapentin ved behandling af angst og panik - Google Patents
Anvendelse af gabapentin ved behandling af angst og panikInfo
- Publication number
- DK0804182T3 DK0804182T3 DK95926249T DK95926249T DK0804182T3 DK 0804182 T3 DK0804182 T3 DK 0804182T3 DK 95926249 T DK95926249 T DK 95926249T DK 95926249 T DK95926249 T DK 95926249T DK 0804182 T3 DK0804182 T3 DK 0804182T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- gabapentin
- anxiety
- panic
- terminal sequence
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title abstract 6
- 229960002870 gabapentin Drugs 0.000 title abstract 3
- 208000019901 Anxiety disease Diseases 0.000 title abstract 2
- 230000036506 anxiety Effects 0.000 title abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract 1
- 206010033664 Panic attack Diseases 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyclic amino acids Chemical class 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28128594A | 1994-07-27 | 1994-07-27 | |
| US08/445,398 US5792796A (en) | 1994-07-27 | 1995-06-06 | Methods for treating anxiety and panic |
| PCT/US1995/008702 WO1996003122A2 (en) | 1994-07-27 | 1995-07-11 | Use of gabapentin in the treatment of anxiety and panic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0804182T3 true DK0804182T3 (da) | 2002-09-09 |
Family
ID=26960801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95926249T DK0804182T3 (da) | 1994-07-27 | 1995-07-11 | Anvendelse af gabapentin ved behandling af angst og panik |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0804182B1 (de) |
| JP (1) | JPH10503490A (de) |
| AT (1) | ATE218334T1 (de) |
| AU (1) | AU703428B2 (de) |
| CA (1) | CA2193384C (de) |
| CZ (1) | CZ291757B6 (de) |
| DE (1) | DE69526972T2 (de) |
| DK (1) | DK0804182T3 (de) |
| ES (1) | ES2176334T3 (de) |
| HU (4) | HU0102041D0 (de) |
| MX (1) | MX9606674A (de) |
| NZ (1) | NZ290050A (de) |
| PL (1) | PL187064B1 (de) |
| PT (1) | PT804182E (de) |
| RO (1) | RO120041B1 (de) |
| RU (1) | RU2168982C2 (de) |
| SK (1) | SK283711B6 (de) |
| WO (1) | WO1996003122A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5712158A (en) * | 1995-06-06 | 1998-01-27 | Warner-Lambert Company | Cell line for the rapid expression of functional calcium channels |
| US6372792B1 (en) | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
| DK0934061T6 (en) | 1996-07-24 | 2015-01-26 | Warner Lambert Co | Isobutylgaba and its derivatives for the treatment of pain |
| WO1999021824A1 (en) | 1997-10-27 | 1999-05-06 | Warner-Lambert Company | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| JP2002516312A (ja) | 1998-05-26 | 2002-06-04 | ワーナー−ランバート・カンパニー | カルシウムチャンネルのα２δサブユニットに対する親和性を有する立体配座的に制約されたアミノ酸化合物 |
| FR2781793B1 (fr) * | 1998-08-03 | 2001-07-20 | Prographarm Lab | Procede de fabrication de granules de gabapentine enrobes |
| EP1214599A2 (de) * | 1999-09-16 | 2002-06-19 | Warner-Lambert Company | Screening-verfahren für alpha2delta-1 untereinheit-bindenden liganden |
| RU2377234C2 (ru) * | 2003-09-17 | 2009-12-27 | Ксенопорт, Инк. | Лечение или предупреждение синдрома беспокойных ног с использованием пролекарств аналогов гамк |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2016465A1 (en) * | 1989-06-02 | 1990-12-02 | Zola Phillip Horovitz | Method for preventing or treating anxiety employing a calcium channel blocker |
| US5189026A (en) * | 1991-06-07 | 1993-02-23 | Fractal Laboratories, Inc. | Treatment of human diseases involving dysregulation or dysfunction of the nervous system |
| DE122004000039I2 (de) * | 1992-05-20 | 2006-06-29 | Univ Northwestern | Gaba und L-Glutaminsa}re analoga zur Behandlung der Epilepsie |
-
1995
- 1995-07-11 CZ CZ1997162A patent/CZ291757B6/cs not_active IP Right Cessation
- 1995-07-11 DK DK95926249T patent/DK0804182T3/da active
- 1995-07-11 HU HU0102041A patent/HU0102041D0/hu unknown
- 1995-07-11 JP JP8505766A patent/JPH10503490A/ja not_active Ceased
- 1995-07-11 CA CA002193384A patent/CA2193384C/en not_active Expired - Fee Related
- 1995-07-11 ES ES95926249T patent/ES2176334T3/es not_active Expired - Lifetime
- 1995-07-11 AU AU30069/95A patent/AU703428B2/en not_active Ceased
- 1995-07-11 RO RO97-00128A patent/RO120041B1/ro unknown
- 1995-07-11 WO PCT/US1995/008702 patent/WO1996003122A2/en active IP Right Grant
- 1995-07-11 PL PL95318268A patent/PL187064B1/pl not_active IP Right Cessation
- 1995-07-11 SK SK90-97A patent/SK283711B6/sk unknown
- 1995-07-11 MX MX9606674A patent/MX9606674A/es active IP Right Grant
- 1995-07-11 HU HU9700238A patent/HU223841B1/hu not_active IP Right Cessation
- 1995-07-11 HU HU0102040A patent/HU0102040D0/hu unknown
- 1995-07-11 RU RU97101109/14A patent/RU2168982C2/ru not_active IP Right Cessation
- 1995-07-11 HU HU0102043A patent/HU0102043D0/hu unknown
- 1995-07-11 NZ NZ290050A patent/NZ290050A/xx unknown
- 1995-07-11 DE DE69526972T patent/DE69526972T2/de not_active Expired - Fee Related
- 1995-07-11 PT PT95926249T patent/PT804182E/pt unknown
- 1995-07-11 AT AT95926249T patent/ATE218334T1/de not_active IP Right Cessation
- 1995-07-11 EP EP95926249A patent/EP0804182B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE218334T1 (de) | 2002-06-15 |
| HU0102041D0 (en) | 2001-07-30 |
| ES2176334T3 (es) | 2002-12-01 |
| RO120041B1 (ro) | 2005-08-30 |
| EP0804182A2 (de) | 1997-11-05 |
| HUT76835A (en) | 1997-11-28 |
| JPH10503490A (ja) | 1998-03-31 |
| MX9606674A (es) | 1997-03-29 |
| PL318268A1 (en) | 1997-05-26 |
| PL187064B1 (pl) | 2004-05-31 |
| CA2193384A1 (en) | 1996-02-08 |
| HU0102043D0 (en) | 2001-07-30 |
| DE69526972T2 (de) | 2002-11-21 |
| HU0102040D0 (en) | 2001-07-30 |
| SK9097A3 (en) | 1998-05-06 |
| CA2193384C (en) | 2002-03-19 |
| CZ16297A3 (en) | 1997-07-16 |
| HU223841B1 (hu) | 2005-02-28 |
| AU703428B2 (en) | 1999-03-25 |
| RU2168982C2 (ru) | 2001-06-20 |
| NZ290050A (en) | 1999-08-30 |
| WO1996003122A3 (en) | 1996-07-18 |
| AU3006995A (en) | 1996-02-22 |
| SK283711B6 (sk) | 2003-12-02 |
| DE69526972D1 (de) | 2002-07-11 |
| WO1996003122A2 (en) | 1996-02-08 |
| CZ291757B6 (cs) | 2003-05-14 |
| EP0804182B1 (de) | 2002-06-05 |
| PT804182E (pt) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200000652A1 (ru) | Кристаллы глюкагоноподобного пептида 1 | |
| ATE245416T1 (de) | Neue fettanaloge zur behandlung von diabetes | |
| BG102619A (en) | Substituted n-[(aminoiminomethyl or aminomethyl) phenyl] propylamides | |
| CO5690612A2 (es) | Mimeticuerpos humanos centrales de la region de bisagra, mimeticos de la eritropoyetina, composiciones, metodos y usos | |
| DE69027865D1 (de) | ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN | |
| ATE346934T1 (de) | Modifizierte pflanzenviren als vektore für heterologe peptide | |
| AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
| DK0804182T3 (da) | Anvendelse af gabapentin ved behandling af angst og panik | |
| AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
| DE60139515D1 (de) | Neue Polypeptide aus Bienengift und dessen Gebrauchsverfahren | |
| NO955067D0 (no) | FVII/TF peptider | |
| ES548052A0 (es) | Procedimiento para preparar peptidos | |
| MXPA02004505A (es) | Peptidos mimeticos para epitope de apolipoproteinab-100 concatamero y peptidos modificados del mismo, y la composicion de vacuna que comprende los mismos. | |
| EA200100314A1 (ru) | Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины | |
| BG101846A (en) | HUMAN DNase I VARIANTS | |
| DK0539465T3 (da) | Anvendelse af 20(R)-22-oxa-D-vitamin-analoger til fremstilling af et farmaceutisk præparat til behandling og/eller forebyggelse af hudaldring | |
| ATE179989T1 (de) | Peptide zur behandlung von allergien | |
| DE3162674D1 (en) | A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it | |
| WO1998029436A3 (en) | Lebetin peptides as platelet aggregation inhibitors |